Mirela Gherban
- The U.S. FDA’s Vaccines and Associated Organic Merchandise Advisory Committee will meet on Could 22 to debate the system for COVID-19 vaccines that will probably be used for the 2025-26 season.
- mRNA vaccines from Moderna (NASDAQ:MRNA) and Pfizer (